Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Iovance Biotherapeutics upgraded to Overweight from Neutral at Piper Sandler » 04:33
01/27/23
01/27
04:33
01/27/23
04:33
IOVA

Iovance Biotherapeutics

$7.68 /

-0.055 (-0.71%)

Piper Sandler analyst…

Piper Sandler analyst Joseph Catanzaro upgraded Iovance Biotherapeutics to Overweight from Neutral with a price target of $14, up from $11. The analyst believes the Biologics License Application filing will get done this quarter, lifileucel has a good likelihood of approval later this year and that the initial launch could surprise to the upside. Near-term expectations "leave clear room for upward revisions," the analyst tells investors in a research note. The firm believes Iovance is now in position to "finally realize" lifileucel's opportunity in post-PD-1 melanoma over the next 12-18 months.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$7.68 /

-0.055 (-0.71%)

IOVA Iovance Biotherapeutics
$7.68 /

-0.055 (-0.71%)

01/24/23 Truist
Iovance Biotherapeutics price target raised to $17 from $16 at Truist
01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
12/08/22 Goldman Sachs
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
IOVA Iovance Biotherapeutics
$7.68 /

-0.055 (-0.71%)

IOVA Iovance Biotherapeutics
$7.68 /

-0.055 (-0.71%)

Recommendations
Iovance Biotherapeutics price target raised to $17 from $16 at Truist » 08:36
01/24/23
01/24
08:36
01/24/23
08:36
IOVA

Iovance Biotherapeutics

$7.01 /

+0.74 (+11.81%)

Truist analyst Asthika…

Truist analyst Asthika Goonewardene raised the firm's price target on Iovance Biotherapeutics to $17 from $16 and keeps a Buy rating on the shares. The company's acquisition of Proleukin is viewed positively as it allows Iovance to secure the supply chain, while providing only incremental sales potential, the analyst tells investors in a research note. Truist is also "encouraged" by the company's data for lifileucel in PD-1 naive mNSCLC as disclosed in Iovance's update, though it adds that the durability of response still needs to be established.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$7.01 /

+0.74 (+11.81%)

IOVA Iovance Biotherapeutics
$7.01 /

+0.74 (+11.81%)

01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
12/08/22 Goldman Sachs
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
IOVA Iovance Biotherapeutics
$7.01 /

+0.74 (+11.81%)

IOVA Iovance Biotherapeutics
$7.01 /

+0.74 (+11.81%)

Hot Stocks
Clinigen divests Proleukin to Iovance Biotherapeutics for GBP 166.7M » 08:10
01/23/23
01/23
08:10
01/23/23
08:10
IOVA

Iovance Biotherapeutics

$6.27 /

+0.1 (+1.62%)

Clinigen Limited has…

Clinigen Limited has entered into an agreement to divest Proleukin to Iovance Biotherapeutics. Terms of the agreement include an upfront payment of GBP 166.7M, a GBP 41.7M milestone payment upon first approval of lifileucel in advanced melanoma, and double-digit Proleukin global sales royalties from Iovance to Clinigen. The transaction is expected to close in the first quarter of 2023, subject to required regulatory approvals and clearances and other customary closing conditions.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$6.27 /

+0.1 (+1.62%)

IOVA Iovance Biotherapeutics
$6.27 /

+0.1 (+1.62%)

01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
12/08/22 Goldman Sachs
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
IOVA Iovance Biotherapeutics
$6.27 /

+0.1 (+1.62%)

IOVA Iovance Biotherapeutics
$6.27 /

+0.1 (+1.62%)

Hot Stocks
Akero Therapeutics appoints Patrick Lamy as SVP, commercial strategyIovance Biotherapeutics » 08:14
01/10/23
01/10
08:14
01/10/23
08:14
AKRO

Akero Therapeutics

$44.08 /

-0.725 (-1.62%)

, IOVA

Iovance Biotherapeutics

$6.16 /

-0.215 (-3.38%)

Akero Therapeutics (AKRO)…

Akero Therapeutics (AKRO) announced the appointment of Patrick Lamy as Senior Vice President, Commercial Strategy. Most recently he served as VP, Commercial at Iovance Biotherapeutics (IOVA), where he was responsible for all pre-launch commercial activities for the first cell therapy for melanoma and cervical cancer.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$6.16 /

-0.215 (-3.38%)

AKRO Akero Therapeutics
$44.08 /

-0.725 (-1.62%)

AKRO Akero Therapeutics
$44.08 /

-0.725 (-1.62%)

12/20/22 Evercore ISI
Madrigal Pharmaceuticals price target raised to $325 from $175 at Evercore ISI
12/19/22 Morgan Stanley
Akero's efruxifermin efficacy still compares favorably, says Morgan Stanley
11/14/22 Cantor Fitzgerald
89bio price target raised to $34 from $27 at Cantor Fitzgerald
11/11/22 RBC Capital
89bio price target lowered to $29 from $35 at RBC Capital
IOVA Iovance Biotherapeutics
$6.16 /

-0.215 (-3.38%)

01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
12/08/22 Goldman Sachs
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
IOVA Iovance Biotherapeutics
$6.16 /

-0.215 (-3.38%)

AKRO Akero Therapeutics
$44.08 /

-0.725 (-1.62%)

  • 15
    Sep
IOVA Iovance Biotherapeutics
$6.16 /

-0.215 (-3.38%)

AKRO Akero Therapeutics
$44.08 /

-0.725 (-1.62%)

AKRO Akero Therapeutics
$44.08 /

-0.725 (-1.62%)

Over a month ago
Recommendations
Barclays views GSK acquisition interest as positive for oncology stocks » 18:55
01/02/23
01/02
18:55
01/02/23
18:55
ARVN

Arvinas

$34.23 /

-0.13 (-0.38%)

, GSK

GSK

$35.13 /

+ (+0.00%)

, REPL

Replimune Group

$27.20 /

-0.58 (-2.09%)

, KURA

Kura Oncology

$12.41 /

+0.165 (+1.35%)

, IOVA

Iovance Biotherapeutics

$6.39 /

+0.12 (+1.92%)

, SNDX

Syndax

$25.46 /

+0.695 (+2.81%)

, SWTX

SpringsWorks Therapeutics

$26.01 /

+1.49 (+6.08%)

, BCYC

Bicycle Therapeutics

$29.51 /

-0.39 (-1.30%)

, KPTI

Karyopharm

$3.41 /

+0.26 (+8.27%)

Barclays analyst Peter…

Barclays analyst Peter Lawson views the Financial Times' report that GSK (GSK) has interest in acquiring companies with a market capitalization in the $1.0B-$2.5B range, are under-the-radar, and with drugs that can be approved in the medium term as positive for the biotech tape. Renewed acquisition activity would help improve biotech sentiment and the overall index performance, Lawson tells investors in a research note. He sees a positive read-through to oncology companies with late-stage assets, namely Arvinas (ARVN), Replimune Group (REPL), Kura Oncology (KURA), Iovance Biotherapeutics (IOVA), Syndax (SNDX), SpringsWorks Therapeutics (SWTX), Bicycle Therapeutics (BCYC) and Karyopharm (KPTI).

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$26.01 /

+1.49 (+6.08%)

SNDX Syndax
$25.46 /

+0.695 (+2.81%)

REPL Replimune Group
$27.20 /

-0.58 (-2.09%)

KURA Kura Oncology
$12.41 /

+0.165 (+1.35%)

KPTI Karyopharm
$3.41 /

+0.26 (+8.27%)

IOVA Iovance Biotherapeutics
$6.39 /

+0.12 (+1.92%)

GSK GSK
$35.13 /

+ (+0.00%)

BCYC Bicycle Therapeutics
$29.51 /

-0.39 (-1.30%)

ARVN Arvinas
$34.23 /

-0.13 (-0.38%)

ARVN Arvinas
$34.23 /

-0.13 (-0.38%)

01/02/23 Wells Fargo
Arvinas downgraded to Equal Weight from Overweight at Wells Fargo
12/05/22 Citi
Arvinas price target lowered to $72 from $88 at Citi
11/23/22 Truist
Arvinas price target lowered to $100 from $170 at Truist
11/23/22 Cantor Fitzgerald
Arvinas price target lowered to $90 from $106 at Cantor Fitzgerald
GSK GSK
$35.13 /

+ (+0.00%)

12/23/22 Raymond James
ProQR Therapeutics price target raised to $5 from $2 at Raymond James
12/21/22 Barclays
Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays
12/15/22 Guggenheim
Vaxcyte initiated with a Buy at Guggenheim on pneumococcal vaccine potential
12/08/22 AlphaValue/Baader
GSK upgraded to Buy from Add at AlphaValue/Baader
REPL Replimune Group
$27.20 /

-0.58 (-2.09%)

12/20/22 Piper Sandler
Piper recommends 'down market cap' biotech exposure for 2023
12/14/22 Piper Sandler
Replimune Group price target raised to $58 from $43 at Piper Sandler
12/12/22 BMO Capital
Replimune Group price target raised to $70 from $40 at BMO Capital
10/14/22 BMO Capital
Replimune Group price target raised to $40 from $30 at BMO Capital
KURA Kura Oncology
$12.41 /

+0.165 (+1.35%)

07/12/22 Cantor Fitzgerald
Kura Oncology initiated with an Overweight at Cantor Fitzgerald
07/12/22 Cantor Fitzgerald
Kura Oncology initiated with an Overweight at Cantor Fitzgerald
02/15/22 Jefferies
Kura Oncology initiated with a Buy at Jefferies
IOVA Iovance Biotherapeutics
$6.39 /

+0.12 (+1.92%)

12/08/22 Goldman Sachs
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
SNDX Syndax
$25.46 /

+0.695 (+2.81%)

12/12/22 H.C. Wainwright
Syndax price target raised to $33 from $31 at H.C. Wainwright
09/20/22 B. Riley
B. Riley replaces Allogene with Syndax as top pick for 2022
07/28/22 B. Riley
Syndax resumed with a Buy at B. Riley
04/11/22 H.C. Wainwright
Syndax initiated with a Buy at H.C. Wainwright
SWTX SpringsWorks Therapeutics
$26.01 /

+1.49 (+6.08%)

12/01/22 BofA
SpringsWorks Therapeutics initiated with a Buy, $45 price target at BofA
12/01/22 BofA
SpringsWorks Therapeutics initiated with a Buy at BofA
09/12/22 H.C. Wainwright
SpringsWorks price target raised to $103 from $94 at H.C. Wainwright
08/09/22 H.C. Wainwright
SpringsWorks Therapeutics price target lowered to $94 from $95 at H.C. Wainwright
BCYC Bicycle Therapeutics
$29.51 /

-0.39 (-1.30%)

11/10/22 Piper Sandler
Bicycle Therapeutics price target raised to $48 from $37 at Piper Sandler
11/09/22 JMP Securities
Bicycle Therapeutics price target lowered to $46 from $70 at JMP Securities
08/31/22 Cowen
Cowen starts Bicycle at Outperform with positive data 'any day now'
08/31/22 Cowen
Bicycle Therapeutics initiated with an Outperform at Cowen
KPTI Karyopharm
$3.41 /

+0.26 (+8.27%)

11/04/22 RBC Capital
Karyopharm upgraded to Outperform from Sector Perform at RBC Capital
11/04/22 RBC Capital
Karyopharm upgraded to Outperform from Sector Perform at RBC Capital
08/05/22 Baird
Karyopharm price target lowered to $14 from $17 at Baird
08/05/22 Barclays
Karyopharm price target lowered to $8 from $14 at Barclays
SWTX SpringsWorks Therapeutics
$26.01 /

+1.49 (+6.08%)

SNDX Syndax
$25.46 /

+0.695 (+2.81%)

REPL Replimune Group
$27.20 /

-0.58 (-2.09%)

KURA Kura Oncology
$12.41 /

+0.165 (+1.35%)

KPTI Karyopharm
$3.41 /

+0.26 (+8.27%)

IOVA Iovance Biotherapeutics
$6.39 /

+0.12 (+1.92%)

GSK GSK
$35.13 /

+ (+0.00%)

BCYC Bicycle Therapeutics
$29.51 /

-0.39 (-1.30%)

ARVN Arvinas
$34.23 /

-0.13 (-0.38%)

  • 09
    Dec
  • 07
    Dec
GSK GSK
$35.13 /

+ (+0.00%)

SNDX Syndax
$25.46 /

+0.695 (+2.81%)

REPL Replimune Group
$27.20 /

-0.58 (-2.09%)

KURA Kura Oncology
$12.41 /

+0.165 (+1.35%)

KPTI Karyopharm
$3.41 /

+0.26 (+8.27%)

IOVA Iovance Biotherapeutics
$6.39 /

+0.12 (+1.92%)

GSK GSK
$35.13 /

+ (+0.00%)

ARVN Arvinas
$34.23 /

-0.13 (-0.38%)

GSK GSK
$35.13 /

+ (+0.00%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:32
12/09/22
12/09
09:32
12/09/22
09:32
NFLX

Netflix

$310.40 /

+1.85 (+0.60%)

, DOCU

DocuSign

$43.78 /

+1.73 (+4.11%)

, COIN

Coinbase

$42.82 /

+1.56 (+3.78%)

, AVGO

Broadcom

$531.27 /

+12.72 (+2.45%)

, CLSK

CleanSpark

$2.12 /

+0.07 (+3.42%)

, CVNA

Carvana

$4.96 /

+1.13 (+29.50%)

, TTWO

Take-Two

$100.80 /

+1.245 (+1.25%)

, JAZZ

Jazz Pharmaceuticals

$150.28 /

-0.93 (-0.62%)

, CS

Credit Suisse

$3.33 /

+0.155 (+4.89%)

, NHI

National Health Investors

$56.47 /

+0.69 (+1.24%)

, IOVA

Iovance Biotherapeutics

$7.17 /

-0.085 (-1.17%)

, AA

Alcoa

$47.33 /

+0.735 (+1.58%)

, LULU

Lululemon

$375.51 /

+2.84 (+0.76%)

, ALIT

Alight

$8.58 /

-0.025 (-0.29%)

, PTEN

Patterson-UTI

$15.69 /

-0.035 (-0.22%)

Institutional investors…

ShowHide Related Items >><<
TTWO Take-Two
$100.80 /

+1.245 (+1.25%)

PTEN Patterson-UTI
$15.69 /

-0.035 (-0.22%)

NFLX Netflix
$310.40 /

+1.85 (+0.60%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CVNA Carvana
$4.96 /

+1.13 (+29.50%)

CS Credit Suisse
$3.33 /

+0.155 (+4.89%)

COIN Coinbase
$42.82 /

+1.56 (+3.78%)

CLSK CleanSpark
$2.12 /

+0.07 (+3.42%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

ALIT Alight
$8.58 /

-0.025 (-0.29%)

AA Alcoa
$47.33 /

+0.735 (+1.58%)

NFLX Netflix
$310.40 /

+1.85 (+0.60%)

12/09/22 Cowen
Netflix price target raised to $405 at Cowen, named a 'Best Idea for 2023'
12/09/22 Wells Fargo
Wells Fargo upgrades Netflix shares on 'more ways to win' in 2023
12/09/22 Wells Fargo
Netflix upgraded to Overweight from Equal Weight at Wells Fargo
11/30/22 Societe Generale
Netflix price target raised to $215 from $170 at Societe Generale
DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

12/09/22 BofA
DocuSign price target lowered to $65 from $80 at BofA
12/09/22 Piper Sandler
DocuSign upgraded to Neutral from Underweight at Piper Sandler
12/06/22 Citi
DocuSign price target lowered to $59 from $76 at Citi
12/05/22 UBS
DocuSign price target lowered to $52 from $65 at UBS
COIN Coinbase
$42.82 /

+1.56 (+3.78%)

12/09/22 Mizuho
Coinbase downgraded to Underperform from Neutral at Mizuho
12/05/22 Atlantic Equities
Coinbase price target lowered to $46 from $67 at Atlantic Equities
12/02/22 Piper Sandler
Piper calls for 'more aggressive headcount reduction' at Coinbase
11/22/22 Needham
Coinbase price target lowered to $73 from $89 at Needham
AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

12/09/22 Truist
Broadcom price target raised to $662 from $630 at Truist
12/09/22 BofA
Broadcom price target raised to $650 from $625 at BofA
12/09/22 Wells Fargo
Broadcom resumed with an Equal Weight at Wells Fargo
12/09/22 Cowen
Broadcom price target raised to $555 from $540 at Cowen
CLSK CleanSpark
$2.12 /

+0.07 (+3.42%)

12/09/22 Cantor Fitzgerald
Cantor starts bitcoin miner CleanSpark at Overweight, says overlooked
12/09/22 Cantor Fitzgerald
CleanSpark initiated with an Overweight at Cantor Fitzgerald
08/10/22 H.C. Wainwright
CleanSpark price target raised to $12 from $6 at H.C. Wainwright
07/26/22 H.C. Wainwright
CleanSpark assumed with a Buy at H.C. Wainwright
CVNA Carvana
$4.96 /

+1.13 (+29.50%)

12/09/22 Jefferies
Vroom price target lowered to $1.10 from $1.30 at Jefferies
12/09/22 Jefferies
Carvana price target lowered to $5 from $10 at Jefferies
12/09/22 Needham
Needham downgrades Carvana, struggles to see near-term path forward
12/09/22 Needham
Carvana downgraded to Hold from Buy at Needham
TTWO Take-Two
$100.80 /

+1.245 (+1.25%)

12/09/22 Citi
Take-Two initiated with a Neutral at Citi
11/28/22 Morgan Stanley
Take-Two price target lowered to $145 from $150 at Morgan Stanley
11/17/22 Truist
Take-Two price target lowered to $131 from $157 at Truist
11/16/22 Truist
Take-Two price target lowered to $131 from $157 at Truist
JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

12/08/22 Goldman Sachs
Jazz Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
11/30/22 Jefferies
Avadel upgraded to Buy at Jefferies after survey of sleep doctors
11/21/22 Needham
Avadel Pharmaceuticals price target raised to $9 from $8 at Needham
11/01/22 H.C. Wainwright
H.C. Wainwright downgrades Zymeworks on Jazz opt-out possibility
CS Credit Suisse
$3.33 /

+0.155 (+4.89%)

12/09/22 BofA
BofA upgrades Credit Suisse to Buy, sees more than 20% upside potential
12/09/22 BofA
Credit Suisse upgraded to Buy from Neutral at BofA
12/01/22 JPMorgan
Credit Suisse price target lowered to CHF 3.80 from CHF 5.50 at JPMorgan
11/07/22 AlphaValue/Baader
Credit Suisse downgraded to Sell from Buy at AlphaValue/Baader
NHI National Health Investors
$56.47 /

+0.69 (+1.24%)

12/09/22 Credit Suisse
National Health upgraded to Neutral from Underperform at Credit Suisse
09/26/22 Truist
National Health Investors price target lowered to $61 from $64 at Truist
08/01/22 Credit Suisse
Credit Suisse sees SNF-exposed REITs reacting positively to reimbursement ruling
06/22/22 Credit Suisse
National Health Investors initiated with an Underperform at Credit Suisse
IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

12/08/22 Goldman Sachs
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
AA Alcoa
$47.33 /

+0.735 (+1.58%)

12/09/22 Morgan Stanley
Alcoa downgraded to Equal Weight from Overweight at Morgan Stanley
10/21/22 B. Riley
Alcoa price target lowered to $37 from $51 at B. Riley
10/20/22 BMO Capital
Alcoa price target lowered to $35 from $40 at BMO Capital
10/06/22 UBS
Alcoa initiated with a Neutral at UBS
LULU Lululemon
$375.51 /

+2.84 (+0.76%)

12/09/22 Morgan Stanley
Lululemon price target raised to $387 from $343 at Morgan Stanley
12/09/22 Jefferies
Jefferies says 'sell shares now' with Lululemon Q3 'as good as it gets'
12/09/22 Wells Fargo
Lululemon price target raised to $360 from $345 at Wells Fargo
12/09/22 Goldman Sachs
Lululemon removed from Conviction Buy list at Goldman on tough comps
ALIT Alight
$8.58 /

-0.025 (-0.29%)

12/09/22 Wedbush
Alight initiated with an Outperform at Wedbush
12/06/22 Needham
Alight initiated with a Buy at Needham
11/08/22 KeyBanc
KeyBanc cuts Benefitfocus to Sector Weight after Q3 results, pending acquisition
09/15/22 KeyBanc
Alight initiated with an Overweight at KeyBanc
PTEN Patterson-UTI
$15.69 /

-0.035 (-0.22%)

12/09/22 Raymond James
Patterson-UTI initiated with a Strong Buy at Raymond James
10/07/22 Piper Sandler
Patterson-UTI assumed with an Overweight at Piper Sandler
09/13/22 Susquehanna
US well completions flat in August but outlook positive, says Susquehanna
08/01/22 Barclays
Patterson-UTI price target raised to $24 from $20 at Barclays
TTWO Take-Two
$100.80 /

+1.245 (+1.25%)

PTEN Patterson-UTI
$15.69 /

-0.035 (-0.22%)

NFLX Netflix
$310.40 /

+1.85 (+0.60%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CVNA Carvana
$4.96 /

+1.13 (+29.50%)

CS Credit Suisse
$3.33 /

+0.155 (+4.89%)

COIN Coinbase
$42.82 /

+1.56 (+3.78%)

CLSK CleanSpark
$2.12 /

+0.07 (+3.42%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

ALIT Alight
$8.58 /

-0.025 (-0.29%)

AA Alcoa
$47.33 /

+0.735 (+1.58%)

  • 15
    Nov
  • 22
    Apr
TTWO Take-Two
$100.80 /

+1.245 (+1.25%)

NFLX Netflix
$310.40 /

+1.85 (+0.60%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CVNA Carvana
$4.96 /

+1.13 (+29.50%)

CS Credit Suisse
$3.33 /

+0.155 (+4.89%)

COIN Coinbase
$42.82 /

+1.56 (+3.78%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

AA Alcoa
$47.33 /

+0.735 (+1.58%)

TTWO Take-Two
$100.80 /

+1.245 (+1.25%)

PTEN Patterson-UTI
$15.69 /

-0.035 (-0.22%)

NHI National Health Investors
$56.47 /

+0.69 (+1.24%)

NFLX Netflix
$310.40 /

+1.85 (+0.60%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CVNA Carvana
$4.96 /

+1.13 (+29.50%)

CS Credit Suisse
$3.33 /

+0.155 (+4.89%)

COIN Coinbase
$42.82 /

+1.56 (+3.78%)

CLSK CleanSpark
$2.12 /

+0.07 (+3.42%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

AA Alcoa
$47.33 /

+0.735 (+1.58%)

TTWO Take-Two
$100.80 /

+1.245 (+1.25%)

PTEN Patterson-UTI
$15.69 /

-0.035 (-0.22%)

NFLX Netflix
$310.40 /

+1.85 (+0.60%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CVNA Carvana
$4.96 /

+1.13 (+29.50%)

CS Credit Suisse
$3.33 /

+0.155 (+4.89%)

COIN Coinbase
$42.82 /

+1.56 (+3.78%)

CLSK CleanSpark
$2.12 /

+0.07 (+3.42%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

AA Alcoa
$47.33 /

+0.735 (+1.58%)

On The Fly
Fly Intel: After-Hours Movers » 18:00
12/08/22
12/08
18:00
12/08/22
18:00
DOCU

DocuSign

$43.78 /

+1.73 (+4.11%)

, AVGO

Broadcom

$531.27 /

+12.72 (+2.45%)

, PHR

Phreesia

$26.67 /

+0.7 (+2.70%)

, RH

RH

$266.37 /

+4.545 (+1.74%)

, MTN

Vail Resorts

$251.07 /

+4.69 (+1.90%)

, BBWI

Bath & Body Works

$42.16 /

-0.85 (-1.98%)

, JAZZ

Jazz Pharmaceuticals

$150.28 /

-0.93 (-0.62%)

, CURV

Torrid

$4.29 /

+0.385 (+9.86%)

, LULU

Lululemon

$375.51 /

+2.84 (+0.76%)

, CHWY

Chewy

$41.98 /

+0.77 (+1.87%)

, IOVA

Iovance Biotherapeutics

$7.17 /

-0.085 (-1.17%)

Check out this evening's…

ShowHide Related Items >><<
RH RH
$266.37 /

+4.545 (+1.74%)

PHR Phreesia
$26.67 /

+0.7 (+2.70%)

MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

12/06/22 Citi
DocuSign price target lowered to $59 from $76 at Citi
12/05/22 UBS
DocuSign price target lowered to $52 from $65 at UBS
12/05/22 Baird
DocuSign price target lowered to $50 from $70 at Baird
11/30/22 Jefferies
DocuSign initiated with a Hold at Jefferies
AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

12/05/22 Susquehanna
Broadcom price target lowered to $650 from $680 at Susquehanna
12/05/22 Piper Sandler
Broadcom price target lowered to $715 from $750 at Piper Sandler
10/27/22 Jefferies
Meta commentary positive for datacenter semi names, says Jefferies
10/18/22 Deutsche Bank
Broadcom price target lowered to $575 from $635 at Deutsche Bank
PHR Phreesia
$26.67 /

+0.7 (+2.70%)

10/13/22 DA Davidson
Phreesia initiated at Neutral at DA Davidson yesterday on valuation
10/12/22 DA Davidson
Phreesia initiated with a Neutral at DA Davidson
09/15/22 KeyBanc
Phreesia initiated with an Overweight at KeyBanc
09/08/22 Piper Sandler
Piper Sandler ups Phreesia price target to $33 following 'strong' Q2 beat
RH RH
$266.37 /

+4.545 (+1.74%)

11/21/22 Barclays
RH downgraded to Equal Weight from Overweight at Barclays
11/18/22 Wedbush
Wedbush downgrades RH on 'course-correction,' deteriorating macro
11/18/22 Wedbush
RH downgraded to Neutral from Outperform at Wedbush
10/31/22 Citi
RH price target lowered to $305 from $338 at Citi
MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

09/29/22 Truist
Vail Resorts price target lowered to $270 from $281 at Truist
09/29/22 Deutsche Bank
Vail Resorts price target lowered to $283 from $286 at Deutsche Bank
09/29/22 Barclays
Vail Resorts price target raised to $224 from $217 at Barclays
09/26/22 Stifel
Vail Resorts price target lowered to $228 from $273 at Stifel
BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

12/07/22 Argus
Bath & Body Works price target raised to $50 from $45 at Argus
11/28/22 Goldman Sachs
Goldman finds small crowds, more promotions over Black Friday weekend
11/18/22 Citi
Bath & Body Works price target raised to $50 from $48 at Citi
11/17/22 Morgan Stanley
Bath & Body Works price target raised to $76 from $72 at Morgan Stanley
JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

12/08/22 Goldman Sachs
Jazz Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
11/30/22 Jefferies
Avadel upgraded to Buy at Jefferies after survey of sleep doctors
11/21/22 Needham
Avadel Pharmaceuticals price target raised to $9 from $8 at Needham
11/01/22 H.C. Wainwright
H.C. Wainwright downgrades Zymeworks on Jazz opt-out possibility
CURV Torrid
$4.29 /

+0.385 (+9.86%)

09/22/22 Morgan Stanley
Torrid price target lowered to $5 from $6.50 at Morgan Stanley
08/04/22 Baird
Torrid price target lowered to $7 from $9 at Baird
07/21/22 Goldman Sachs
Torrid price target lowered to $4 from $5.50 at Goldman Sachs
07/15/22 Cowen
Torrid downgraded to Market Perform at Cowen on low income consumer exposure
LULU Lululemon
$375.51 /

+2.84 (+0.76%)

12/07/22 Deutsche Bank
Lululemon price target raised to $450 from $434 at Deutsche Bank
12/06/22 Raymond James
Lululemon price target raised to $438 from $345 at Raymond James
12/05/22 Stifel
Lululemon price target raised to $450 from $400 at Stifel
12/05/22 Cowen
Lululemon price target raised to $542 from $535 at Cowen
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

12/07/22 Wolfe Research
Chewy downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/21/22 Deutsche Bank
Chewy price target raised to $50 from $40 at Deutsche Bank
11/15/22 MoffettNathanson
Chewy initiated with a Market Perform at MoffettNathanson
IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

12/08/22 Goldman Sachs
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
RH RH
$266.37 /

+4.545 (+1.74%)

PHR Phreesia
$26.67 /

+0.7 (+2.70%)

MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

RH RH
$266.37 /

+4.545 (+1.74%)

PHR Phreesia
$26.67 /

+0.7 (+2.70%)

MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

RH RH
$266.37 /

+4.545 (+1.74%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

Downgrade
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs » 17:09
12/08/22
12/08
17:09
12/08/22
17:09
IOVA

Iovance Biotherapeutics

$7.17 /

-0.085 (-1.17%)

Goldman Sachs analyst…

Goldman Sachs analyst Madhu Kumar downgraded Iovance Biotherapeutics to Neutral from Buy with a price target of $6, down from $20. The analyst is citing concerns around the clinical, regulatory, financing, competitive, and commercial path for the company's lead asset, tumor-infiltrating lymphocyte drug lifileucel in metastatic melanoma, MM. While lifileucel has shown "promising efficacy" in post-PD-1 MM, he sees the potential for "multiple headwinds" for the drug's commercialization, Kumar tells investors in a research note. The analyst adds that he also sees potential for lifileucel in post-PD-1/chemo cervical cancer and LN-145 in post-PD-1 non-small cell lung cancer, but there is a lack of a "defined catalyst path" for these programs.

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
11/18/22 Oppenheimer
Iovance price target lowered to $25 from $27 at Oppenheimer
IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:27
12/07/22
12/07
11:27
12/07/22
11:27
NYMX

Nymox

/

+

, ONCT

Oncternal Therapeutics

$1.05 /

-0.025 (-2.33%)

, IOVA

Iovance Biotherapeutics

$7.56 /

-0.04 (-0.53%)

, PLX

Protalix

$1.17 /

-0.01 (-0.85%)

, CDMO

Avid Bioservices

$12.80 /

-2.04 (-13.75%)

These names in the…

ShowHide Related Items >><<
PLX Protalix
$1.17 /

-0.01 (-0.85%)

ONCT Oncternal Therapeutics
$1.05 /

-0.025 (-2.33%)

NYMX Nymox
/

+

IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

CDMO Avid Bioservices
$12.80 /

-2.04 (-13.75%)

NYMX Nymox
/

+

ONCT Oncternal Therapeutics
$1.05 /

-0.025 (-2.33%)

08/10/22 H.C. Wainwright
Oncternal Therapeutics price target lowered to $7 from $8 at H.C. Wainwright
05/27/22 Northland
Oncternal updated interim data should be catalyst for shares, says Northland
05/10/22 Maxim
Oncternal Therapeutics initiated with a Buy at Maxim
02/24/22 BTIG
Oncternal Therapeutics initiated with a Buy at BTIG
IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
11/18/22 Oppenheimer
Iovance price target lowered to $25 from $27 at Oppenheimer
PLX Protalix
$1.17 /

-0.01 (-0.85%)

CDMO Avid Bioservices
$12.80 /

-2.04 (-13.75%)

12/07/22 Craig-Hallum
Avid Bioservices price target lowered to $25 from $30 at Craig-Hallum
06/30/22 RBC Capital
Avid Bioservices price target lowered to $22 from $32 at RBC Capital
03/09/22 Craig-Hallum
Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
12/08/21 RBC Capital
Avid Bioservices price target raised to $32 from $27 at RBC Capital
ONCT Oncternal Therapeutics
$1.05 /

-0.025 (-2.33%)

IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

CDMO Avid Bioservices
$12.80 /

-2.04 (-13.75%)

NYMX Nymox
/

+

IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

CDMO Avid Bioservices
$12.80 /

-2.04 (-13.75%)

IOVA Iovance Biotherapeutics
$7.56 /

-0.04 (-0.53%)

On The Fly
What You Missed On Wall Street On Monday » 16:52
12/05/22
12/05
16:52
12/05/22
16:52
CRM

Salesforce

$133.87 /

-10.695 (-7.40%)

, IOVA

Iovance Biotherapeutics

$8.04 /

+1.195 (+17.46%)

, BP

BP

$35.01 /

-0.355 (-1.00%)

, COP

ConocoPhillips

$119.37 /

-2.385 (-1.96%)

, SHEL

Shell

$57.41 /

-0.29 (-0.50%)

, TTE

TotalEnergies

$59.71 /

-0.97 (-1.60%)

, XOM

Exxon Mobil

$106.80 /

-3.035 (-2.76%)

, CVX

Chevron

$176.63 /

-4.32 (-2.39%)

, USO

United States Oil Fund

$67.71 /

-2.13 (-3.05%)

, VFC

VF Corp.

$29.52 /

-3.7 (-11.14%)

, NBTB

NBT Bancorp

$43.38 /

-2.94 (-6.35%)

, SAL

Salisbury Bancorp

$31.23 /

+0.14 (+0.45%)

, TSLA

Tesla

$182.42 /

-12.43 (-6.38%)

, AAPL

Apple

$146.61 /

-1.21 (-0.82%)

, SBUX

Starbucks

$103.59 /

-1.44 (-1.37%)

, DPZ

Domino's Pizza

$380.98 /

-1.24 (-0.32%)

, UAL

United Airlines

$45.03 /

+1.14 (+2.60%)

, MGM

MGM Resorts

$37.81 /

+0.74 (+2.00%)

, SI

Silvergate Capital

$24.24 /

-2.225 (-8.41%)

, RXT

Rackspace Technology

$4.10 /

-0.75 (-15.48%)

, CVS

CVS Health

$102.01 /

-0.55 (-0.54%)

, PINS

Pinterest

$23.96 /

-0.895 (-3.60%)

, NKE

Nike

$109.64 /

-2.55 (-2.27%)

, CS

Credit Suisse

$3.35 /

-0.035 (-1.04%)

, CWK

Cushman & Wakefield

$12.26 /

+0.295 (+2.47%)

, HZNP

Horizon Therapeutics

$98.55 /

-6.275 (-5.99%)

, JNJ

Johnson & Johnson

$178.79 /

-0.05 (-0.03%)

, FTCH

Farfetch

$5.45 /

-0.54 (-9.02%)

, SAIC

SAIC

$113.98 /

+5.145 (+4.73%)

, VERU

Veru

$5.80 /

+0.295 (+5.36%)

, SLG

SL Green Realty

$38.07 /

-2.58 (-6.35%)

, ENLV

Enlivex Therapeutics

$4.41 /

-0.07 (-1.56%)

, NTRB

Nutriband

$3.82 /

+0.045 (+1.19%)

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TTE TotalEnergies
$59.71 /

-0.97 (-1.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

SAIC SAIC
$113.98 /

+5.145 (+4.73%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NTRB Nutriband
$3.82 /

+0.045 (+1.19%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

NBTB NBT Bancorp
$43.38 /

-2.94 (-6.35%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

12/05/22 KeyBanc
Veeva price target lowered to $210 from $220 at KeyBanc
12/05/22 Credit Suisse
Salesforce price target lowered to $225 from $250 at Credit Suisse
12/05/22 Citi
Salesforce price target lowered to $164 from $170 at Citi
12/02/22 Morgan Stanley
Veeva assumed with an Equal Weight at Morgan Stanley
IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
11/18/22 Oppenheimer
Iovance price target lowered to $25 from $27 at Oppenheimer
BP BP
$35.01 /

-0.355 (-1.00%)

12/02/22 JPMorgan
BP price target raised to 560 GBp from 530 GBp at JPMorgan
11/22/22 Citi
BP upgraded to Buy from Neutral at Citi
11/14/22 Wells Fargo
Archaea Energy downgraded to Equal Weight from Overweight at Wells Fargo
11/11/22 Piper Sandler
BP price target raised to $40 from $37 at Piper Sandler
COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

11/22/22 Citi
ConocoPhillips price target raised to $160 from $132 at Citi
11/21/22 Argus
ConocoPhillips price target raised to $150 from $125 at Argus
11/21/22 Societe Generale
ConocoPhillips downgraded to Sell on valuation at Societe Generale
11/21/22 Societe Generale
ConocoPhillips downgraded to Sell from Hold at Societe Generale
SHEL Shell
$57.41 /

-0.29 (-0.50%)

12/02/22 JPMorgan
Shell price target raised to 2,950 GBp from 2,900 GBp at JPMorgan
11/11/22 Piper Sandler
Shell price target raised to $71 from $65 at Piper Sandler
11/08/22 Morgan Stanley
Shell price target raised to 2,922 GBp from 2,860 GBp at Morgan Stanley
11/06/22 Goldman Sachs
Shell downgraded to Neutral from Buy at Goldman Sachs
TTE TotalEnergies
$59.71 /

-0.97 (-1.60%)

12/02/22 JPMorgan
TotalEnergies price target raised to EUR 68 from EUR 66 at JPMorgan
12/02/22 JPMorgan
TotalEnergies added to Analyst Focus List at JPMorgan
11/11/22 Piper Sandler
TotalEnergies price target raised to $66 from $58 at Piper Sandler
11/08/22 Morgan Stanley
TotalEnergies price target raised to EUR 65 from EUR 58 at Morgan Stanley
XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

11/22/22 Citi
Exxon Mobil price target raised to $110 from $98 at Citi
11/11/22 Piper Sandler
Exxon Mobil price target raised to $131 from $113 at Piper Sandler
11/01/22 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
10/31/22 Truist
Exxon Mobil price target raised to $114 from $111 at Truist
CVX Chevron
$176.63 /

-4.32 (-2.39%)

11/22/22 Citi
Chevron price target raised to $180 from $155 at Citi
11/11/22 Piper Sandler
Chevron price target raised to $206 from $186 at Piper Sandler
10/31/22 Cowen
Chevron price target raised to $185 from $160 at Cowen
10/24/22 HSBC
Chevron downgraded to Hold from Buy at HSBC
USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

12/06/22 Baird
VF Corp. removed from bullish Fresh Pick at Baird
12/05/22 Deutsche Bank
VF Corp. risk/reward favorable with bar reset, says Deutsche Bank
12/05/22 Credit Suisse
Credit Suisse downgrades VF Corp. after 'abrupt' CEO transition
12/05/22 Credit Suisse
VF Corp. downgraded to Neutral from Outperform at Credit Suisse
NBTB NBT Bancorp
$43.38 /

-2.94 (-6.35%)

12/06/22 Janney Montgomery Scott
Salisbury Bancorp downgraded to Neutral at Janney after NBT Bancorp deal
01/09/22 Keefe Bruyette
NBT Bancorp assumed with a Market Perform at Keefe Bruyette
SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

12/06/22 Janney Montgomery Scott
Salisbury Bancorp downgraded to Neutral from Buy at Janney Montgomery Scott
TSLA Tesla
$182.42 /

-12.43 (-6.38%)

12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
11/30/22 Wedbush
China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

12/05/22 Deutsche Bank
Starbucks downgraded to Hold from Buy at Deutsche Bank
11/04/22 Evercore ISI
Starbucks price target raised to $97 from $95 at Evercore ISI
11/04/22 Citi
Starbucks price target raised to $93 from $90 at Citi
11/04/22 Wedbush
Starbucks price target raised to $96 from $92 at Wedbush
DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

12/05/22 BTIG
Domino's Pizza upgraded to Buy from Neutral at BTIG
11/30/22 Citi
Domino's Pizza price target raised to $441 from $407 at Citi
11/18/22 Northcoast
Domino's Pizza upgraded to Buy from Neutral at Northcoast
10/14/22 BMO Capital
Domino's Pizza price target lowered to $400 from $430 at BMO Capital
UAL United Airlines
$45.03 /

+1.14 (+2.60%)

12/06/22 Argus
United Airlines upgraded to Buy from Hold at Argus
12/05/22 Morgan Stanley
United Airlines upgraded to Overweight from Equal Weight at Morgan Stanley
10/25/22 Cowen
Mesa Air price target lowered to $1.50 from $4.00 at Cowen
10/21/22 Citi
United Airlines price target raised to $65 from $56 at Citi
MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

12/05/22 Truist
MGM Resorts upgraded to Buy at Truist amid returning activity at the Strip
12/05/22 Truist
MGM Resorts upgraded to Buy from Hold at Truist
11/28/22 Jefferies
Macau concession renewals removes overhang for incumbents, says Jefferies
11/28/22 JPMorgan
DraftKings downgraded to Underweight from Neutral at JPMorgan
SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

12/05/22 Morgan Stanley
Silvergate Capital downgraded to Underweight from Equal Weight at Morgan Stanley
11/29/22 Keefe Bruyette
Silvergate exposure to BlockFi 'very modest,' says Keefe Bruyette
11/25/22 Morgan Stanley
Silvergate Capital price target lowered to $24 from $37 at Morgan Stanley
11/22/22 BTIG
Silvergate Capital price target lowered to $51 from $135 at BTIG
RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

11/21/22 Citi
Rackspace Technology price target lowered to $5 from $7 at Citi
11/10/22 Deutsche Bank
Rackspace Technology price target lowered to $5 from $6 at Deutsche Bank
10/11/22 Evercore ISI
Rackspace Technology downgraded to In Line at Evercore ISI on 2023 risks
10/11/22 Evercore ISI
Rackspace Technology downgraded to In Line from Outperform at Evercore ISI
CVS CVS Health
$102.01 /

-0.55 (-0.54%)

11/23/22 Morgan Stanley
CVS Health assumed with an Overweight at Morgan Stanley
11/21/22 Credit Suisse
CVS Health price target raised to $125 from $117 at Credit Suisse
11/06/22 Raymond James
CVS Health price target lowered to $115 from $120 at Raymond James
11/02/22 B. Riley
B. Riley downgrades Semler Scientific on risk from Signify buyout
PINS Pinterest
$23.96 /

-0.895 (-3.60%)

10/31/22 Citi
Pinterest price target raised to $26 from $25 at Citi
10/28/22 Stifel
Pinterest 'a rare bright spot thus far through earnings,' says Stifel
10/28/22 Barclays
Pinterest price target raised to $25 from $23 at Barclays
10/28/22 Piper Sandler
Pinterest price target raised to $25 from $23 at Piper Sandler
NKE Nike
$109.64 /

-2.55 (-2.27%)

11/22/22 Cowen
Nike price target raised to $118 from $114 at Cowen
11/07/22 Stifel
Deckers Brands price target raised to $416 from $390 at Stifel
10/13/22 Raymond James
Nike initiated with an Outperform at Raymond James
10/12/22 Raymond James
Nike initiated with an Outperform at Raymond James
CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

12/01/22 JPMorgan
Credit Suisse price target lowered to CHF 3.80 from CHF 5.50 at JPMorgan
11/07/22 AlphaValue/Baader
Credit Suisse downgraded to Sell from Buy at AlphaValue/Baader
10/28/22 JPMorgan
Credit Suisse price target lowered to CHF 5.50 from CHF 6 at JPMorgan
10/06/22 JPMorgan
Credit Suisse upgraded to Neutral from Underweight at JPMorgan
CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

07/22/22 Raymond James
Cushman & Wakefield removed from Analyst Current Favorites list at Raymond James
04/21/22 Citi
Cushman & Wakefield price target lowered to $21 from $23 at Citi
04/05/22 Goldman Sachs
Cushman & Wakefield initiated with a Buy at Goldman Sachs
03/10/22 Wolfe Research
Cushman & Wakefield price target lowered to $28 from $44 at Wolfe Research
HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

12/01/22 Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

12/05/22 Cowen
Farfetch price target lowered to $8 from $11 at Cowen
12/02/22 Wells Fargo
Farfetch price target lowered to $18 from $25 at Wells Fargo
12/02/22 JPMorgan
Farfetch selloff on financial outlook overdone, says JPMorgan
12/02/22 BTIG
Farfetch price target lowered to $10 from $13 at BTIG
SAIC SAIC
$113.98 /

+5.145 (+4.73%)

12/06/22 Truist
SAIC price target raised to $120 from $105 at Truist
12/06/22 Wells Fargo
SAIC price target raised to $121 from $99 at Wells Fargo
12/05/22 Stifel
SAIC price target raised to $110 from $99 at Stifel
11/17/22 Jefferies
SAIC downgraded to Hold at Jefferies on lower growth than peers
VERU Veru
$5.80 /

+0.295 (+5.36%)

11/10/22 H.C. Wainwright
Veru price target lowered to $21 from $24 at H.C. Wainwright
09/20/22 Oppenheimer
Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged'
09/08/22 Oppenheimer
Oppenheimer remains bullish on Veru, optimism for EUA unchanged
08/11/22 Cantor Fitzgerald
Veru price target raised to $30 from $24 at Cantor Fitzgerald
SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

12/06/22 Scotiabank
Scotiabank downgrades SL Green with balance sheet looking 'stressed'
12/06/22 BMO Capital
SL Green Realty downgraded to Market Perform from Outperform at BMO Capital
12/06/22 Scotiabank
SL Green Realty downgraded to Underperform from Sector Perform at Scotiabank
11/23/22 Morgan Stanley
SL Green Realty price target lowered to $38 from $44 at Morgan Stanley
ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

05/02/22 H.C. Wainwright
Enlivex Therapeutics price target lowered to $15 from $33 at H.C. Wainwright
NTRB Nutriband
$3.82 /

+0.045 (+1.19%)

XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

SAIC SAIC
$113.98 /

+5.145 (+4.73%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NTRB Nutriband
$3.82 /

+0.045 (+1.19%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

NBTB NBT Bancorp
$43.38 /

-2.94 (-6.35%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

  • 07
    Dec
XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

TTE TotalEnergies
$59.71 /

-0.97 (-1.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

SAIC SAIC
$113.98 /

+5.145 (+4.73%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.